Bluebell vs Danone — How a $20M Stake Ousted the CEO of a $30B Company in 117 Days

The European packaged food and beverage industry was worth roughly €1 trillion by 2020 and dominated by three majors, Nestlé in Switzerland, Unilever in the UK and Netherlands, and Danone in France. Through the mid- and late 2010s all three faced the same structural pressures, namely the rise of D2C and challenger brands such as Oatly and Beyond Meat, eroding pricing power, rising input costs and growing ESG demands. Their responses diverged. Nestlé treated Third Point's 2017 activist campaign as an accelerant for its own portfolio overhaul, lifting its EBIT margin from 16% to 17.5–18.5% and seeing its share price rise more than 50% over the following years. Unilever fended off Kraft Heinz's 2017 hostile approach and embarked on its own restructuring. Danone chose a third path of ESG and Entreprise à Mission, and ended the decade trailing its peers by more than 60 percentage points of TSR. Bluebell's November 2020 letter was a signal that capital markets would no longer tolerate that gap.

Bluebell's Danone campaign pushed European activism up a notch in sophistication. Until then, mega-cap activism in Europe was typically associated with stakes of 3–5% or more and full-blown proxy contests, as in TCI's 2008 fight at CSX or Elliott's 2018 campaign at Telecom Italia. Bluebell achieved a comparable outcome with a 0.06% holding by combining a rigorous public letter, sustained media engagement and the eventual support of a much larger shareholder. After Faber's ouster, Bluebell deployed the same playbook against Glencore, Vivendi, Solvay, GSK and BlackRock, demonstrating that small-stake mega-cap activism in Europe was no longer a one-off.

Danone was founded in 1919 in Barcelona by the Greek-born physician Isaac Carasso, who built a small business selling yoghurt as a digestive remedy. The company moved its headquarters to Paris in 1929 and grew into one of Europe's leading food and beverage groups, listed on Euronext Paris and a constituent of the CAC 40 under the ticker BN. Its three core divisions are Essential Dairy and Plant-Based, encompassing Activia, Actimel and Alpro, Waters, including Evian, Volvic and Badoit, and Specialised Nutrition, anchored by Aptamil infant formula and medical nutrition. Revenue peaked at €25.3bn in FY2019 before falling to €23.6bn in FY2020 on Covid-19, with the trading operating margin slipping from 12.8% to 11.8%. Over the same period, Nestlé and Unilever defended or expanded their margins, and that divergence sat at the heart of Bluebell's case.

This was an activist campaign rather than an M&A transaction, so the formal capital structure of Danone did not change. The before-and-after picture is about who held the CEO and chairman titles, and how the governance structure was reconfigured. Bluebell ran the entire campaign through public letters and coalition building, without filing a proxy contest, a shareholder proposal or any legal action. The case is a textbook example of governance change driven by argument rather than by votes.

As an activist campaign rather than a transaction, the advisory lineup differs from a typical M&A deal. Bluebell ran the campaign in-house, with Bivona and Taricco leading research, drafting and media strategy themselves. External legal advice on the activist side was reportedly limited and country-specific. Danone retained its long-standing investment banking and law firm relationships, while Artisan handled its public letters through an internal governance team.

Note, advisor information is drawn from public reporting and market commentary. Bluebell and Artisan ran the campaign primarily in-house, and Danone has not formally disclosed the full list of external advisers it retained. Mandates and scope may differ from those reported.

Unit: EUR millions. IFRS consolidated basis. Source: Danone Universal Registration Document FY2015–FY2020. The 2017 step-up in revenue reflects the WhiteWave acquisition in the US organic foods segment. The 6.6% drop in FY2020 reflects Covid-19 impact on out-of-home consumption, waters and the global infant nutrition business.

The core valuation argument was deliberately simple, namely that Danone had underperformed its peers by more than 60 percentage points of total shareholder return over the six years of Faber's tenure. One number, repeated consistently, drained Danone's qualitative defence of much of its force. From September 2014 to December 2020, Danone returned about 21% in TSR, against 56% for the Stoxx Europe 600 Food & Beverage index, 97% for Nestlé and 101% for Unilever. For a long-only holder in European food, Danone had captured less than a third of the sector's average return.

Note, share-price and TSR figures are based on Bloomberg, Refinitiv and Danone IR disclosures. The exact entry and exit prices of Bluebell and Artisan are not public, so short-term capital gains are estimates.

Bluebell vs Danone has entered the activist canon as the first case in which a clearly small stake removed a mega-cap CEO largely through argument. The longer-term operational record is more ambiguous. Under Antoine de Saint-Affrique, Danone struggled with input-cost inflation, FX headwinds, weakness in the China infant-nutrition business and limited pricing power in EDP. By mid-2023, the shares had retreated to about €50, broadly in line with where they had been before the campaign. The campaign demonstrated both the speed at which activism can change governance and the slower, harder work of restoring operating performance. Bluebell itself capitalised on the franchise effect, deploying the same playbook against Glencore, Vivendi, Solvay, GSK and BlackRock, and embedding the small-stake-plus-large-holder model as a feature of European corporate life.